NuCana (NCNA) Change in Receivables (2017 - 2025)

NuCana (NCNA) reported Change in Receivables of $2.8 million for Q4 2025, up 832.28% on a YoY basis from $304189.9 in Q4 2024, and up 210.04% sequentially from -$2.6 million in Q3 2025.

NuCana (NCNA) Change in Receivables (2017 - 2025) Analysis & Trends

NuCana (NCNA) has 9 years of Change in Receivables data on file, last reported at $2.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables rose 832.28% year-over-year to $2.8 million; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (up 25.47% YoY), and the FY2025 full-year result was $143717.6, down 93.53% from the prior year.
  • Change in Receivables advanced to $2.8 million in Q4 2025, from -$2.6 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $2.8 million in Q4 2025 to a low of -$2.6 million in Q3 2025.
  • A 5-year average of $353468.8 and a median of $413752.9 in 2022 frame the typical range for Change in Receivables.
  • Across the five-year window, Change in Receivables surged 1931.52% in 2023 and slumped 326.7% in 2025, its largest moves.
  • Tracing NCNA's Change in Receivables over 5 years: stood at $859602.9 in 2021, then sank by 113.92% to -$119634.8 in 2022, then jumped by 829.33% to $872529.8 in 2023, then sank by 65.14% to $304189.9 in 2024, then surged by 832.28% to $2.8 million in 2025.
  • Business Quant data shows NCNA's Change in Receivables at $2.8 million in Q4 2025, -$2.6 million in Q3 2025, and $304189.9 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 75.30 Mn
4 NuCana 279.75 Bn 279.75 Bn - 2.84 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -39.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 110.42 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.84 Mn
Dec 31, 2025 2.84 Mn
Sep 30, 2025 -2.58 Mn
Sep 30, 2025 -2.58 Mn
Dec 31, 2024 304,189.94
Dec 31, 2024 304,189.94
Sep 30, 2024 1.14 Mn
Sep 30, 2024 1.14 Mn
Dec 31, 2023 872,529.78
Dec 31, 2023 872,529.78
Sep 30, 2023 -958,880.39
Sep 30, 2023 -958,880.39
Jun 30, 2023 2.19 Mn
Jun 30, 2023 2.19 Mn
Mar 31, 2023 -562,780.91
Mar 31, 2023 -562,780.91
Jun 30, 2022 -119,634.85
Jun 30, 2022 -119,634.85
Mar 31, 2022 523,315.92
Mar 31, 2022 523,315.92